Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography
|
|
- Lionel Hensley
- 5 years ago
- Views:
Transcription
1 Molecular Psychiatry (1998) 4, Stockton Press All rights reserved /98 $12.00 ORIGINAL RESEARCH ARTICLE Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography J Tiihonen 1, H Vilkman 2,PRäsänen 3, O-P Ryynänen 4, H Hakko 3, J Bergman 5,THämäläinen 1, A Laakso 2, M Haaparanta-Solin 5, O Solin 5, M Kuoppamäki 2, E Syvälahti 2 and J Hietala 6 1 Department of Forensic Psychiatry, University of Kuopio, Niuvanniemi Hospital, FIN Kuopio; 2 Department of Pharmacology and Clinical Pharmacology, University of Turku, FIN Turku; 3 Department of Psychiatry, University of Oulu, Peltolantie 5, FIN Oulu; 4 Department of Public Health Science and General Practice, University of Kuopio, PO Box 1777, FIN Kuopio; 5 Turku PET Center, Accelerator Laboratory, Medicity PET, FIN Turku; 6 Department of Psychiatry, Turku University Central Hospital, FIN Turku, Finland Recent in vivo studies have shown low dopamine D 2 receptor and dopamine transporter densities among late onset (type 1) alcoholics. We have now studied 6-[ 18 F]-FDOPA (FDOPA) uptake in 10 type 1 alcoholics and eight matched controls to test the hypothesis that striatal presynaptic dopamine function is lower among alcoholics. Markedly low FDOPA uptake (K i ) was observed in the left caudate of two alcoholic patients, but the mean striatal uptake values of the patient group were higher than those of the control group. The greatest difference was observed in the mean FDOPA intake in the left putamen, which was 28% higher in the patient group (t = 3.00, P = 0.008, d.f. = 16, independent samples t-test), and in the right caudate (difference 36%, t = 2.87, P = 0.01). The elevated FDOPA uptake in putamen and caudate correlated with poor Wisconsin Card Sorting Test (WCST) performance (error %) among alcoholics (correlation coefficients from 0.49 to 0.56), which suggests that the magnitude of presynaptic dopamine function alteration correlates with the degree of disability to modify one s behavior. The results do not give support to the hypothesis of generally decreased striatal dopamine turnover in type 1 alcoholism, but on the contrary indicate an increased presynaptic dopamine function. This may represent a compensatory mechanism to low postsynaptic DA function. The low presynaptic DA function observed in the left caudate of two patients suggests that type 1 alcoholism may be a heterogeneous disorder. Keywords: dopamine; alcoholism; striatum; PET Introduction Data obtained from animal studies imply that the development of alcohol dependence is associated with the dopamine (DA) function in the striatum and the limbic system. 1 7 Many genetic studies of humans have suggested that the D 2 receptor gene allele A1 is associated with substance abuse, 8 11 but several other studies have given controversial results Our previous in vivo study with positron emission tomography (PET) showed that striatal D 2 receptor density and affinity were reduced in late-onset, non-violent alcoholic subjects (reminiscent of Cloninger type 1 alcoholics) 19 when compared with healthy controls. 20 Recently we observed that the striatal dopamine re-uptake site densities are markedly lower among non-violent alcoholics than in healthy controls while habitually violent alcoholics (reminiscent of Cloninger type 2) 19 have slightly higher DA transporter densities than con- Correspondence: J Tiihonen, University of Kuopio, Department of Forensic Psychiatry, Niuvanniemi Hospital, FIN-70240, Finland Received 10 July 1997; revised 30 October and 5 December 1997; accepted 5 December 1997 trols. 21 These findings on D 2 receptors and DA transporters have been regarded as the first identification of a specific neuroregulatory deficit in type 1 alcoholism. 22 Results of a recent PET study on alcoholics showed lower D 2 -receptor density, but DA transporter densities were not decreased among five alcoholic patients with a mean alcoholism onset age of 19 years (implying that many of these subjects were possibly type 2 rather than type 1 alcoholics). 23 The aim of this study was to measure the presynaptic dopamine function with PET and 6-[ 18 F]-fluorodopa (FDOPA) uptake to test the hypothesis that overall dopaminergic turnover is lower in the striatum of type 1 19 alcoholics when compared with healthy controls. Material and methods Index subjects and controls The procedure was approved by the local ethical committees (Kuopio University Hospital and Turku University/Turku University Central Hospital) and all subjects gave written informed consent. All 18 subjects were white caucasian Finnish citizens. FDOPA uptake was studied with PET in eight age- and sex-matched
2 healthy control subjects with no neurological or psychiatric disorders nor any kind of medication (all males, aged years, mean 44.2 years, all righthanded), and in 10 non-violent alcoholics (all males, aged years, mean 47.7 years, all right-handed). The background data on controls and patients are shown in Table 1. Three alcoholics were omitted from the original sample of 13 subjects because of non-compliance to study protocol. All subjects were recruited with the help of a local rehabilitation center for alcoholics, where they had obtained non-pharmacological treatment for alcoholism. The subjects were selected from the patient population by a psychiatric nurse who chose those subjects who had little or no psychiatric or somatic co-morbidity and were known not to be using antidepressants, neuroleptics, nor other psychotropic drugs. All patients had had difficulties in their jobs due to their alcoholism, but none of them had committed any criminal offence. All of them fulfilled the criteria for Cloninger type 1 alcoholism. 19 The onset of the dependence was defined as the first time of occurrence of significant difficulties in their job, social relationships or health condition. Their abstinence time prior to PET measurement ranged from 3 days to 42 months (mean ± s.d ± days). All patients were interviewed by a psychologist and completed the structured interview questionnaires of the Michigan Alcoholism Screening Test (MAST), Severity of Alcohol Dependence Questionnaire (SADQ), Zung depression and anxiety scales, and Hopkins Symptom Checklist (90-SCL). All subjects were also studied using the Wechsler Adult Intelligence Scale Revised (WAIS-R) and Wisconsin Card Sorting Test (WCST). PET procedure 6-[ 18 F]-FDOPA preparation and HPLC analysis of unchanged FDOPA and labeled metabolites in arterial plasma were performed as described. 24 The PET experiments were performed using a whole-body PET scanner (ECAT 931/08-12). 25 Radioactivity in the brain was measured for 60 min after giving 4 5 mci 6-[ 18 F]- L-FDOPA intravenously. Karbidopa 100 mg p.o. was given 1.5 h before the study. The head was fixed in a vacuum head holder which was further stabilized with glass fiber tape. The positioning of the head in the gantry was according to the cantho-meatal line. Laser beams in the gantry and ink marks on the head were used to control the position of the head. Region-ofinterest (ROI) definitions were based on MRI images Dopamine function in alcoholism without knowledge of diagnosis. Each patient/control underwent a T1 weighted MRI scan (Siemens) with 1.5- mm slice thickness (3D-MPRAGE sequence, TR 10 ms, TE 4 ms). PET-MRI image alignment was done by using a surface-fitting procedure 26 and subsequent MRI image reslicing to match the two middlemost PET planes transversing the striatum. Occipital cortical ROIs were also defined on these slices. K i values reflecting uptake and decarboxylation of [ 18 F]FDOPA by the dopaminergic nerve terminals were calculated by using a graphical analysis 27 with arterial plasma input and occipital cortex as a dopamine nerve terminal-free reference area. Results The fraction of unchanged 6-[ 18 F]-FDOPA in arterial plasma was slightly lower in patients (Figure 1). Fractions of the 3-O-methyl metabolite were identical in controls and patients. Figure 2 demonstrates the 6[ 18 F]- FDOPA and MRI-scans in an alcoholic subject in two consecutive slices. The ligand uptake is markedly low in the left caudate, but the MRI shows no structural abnormalities in the same region. The average FDOPA K i values in the putamen and caudate among controls and index subjects are shown in Table 2, and the scatter plots of the K i values in the caudate and the putamen among different individuals in Figure 3. The results show that the FDOPA K i values are 39 59% lower in the left caudate of two alcoholic patients when compared with the mean value of controls. The mean striatal FDOPA uptake values were 9 36% higher in the alcoholic group, but the differences between the groups were statistically significant (also with Bonferroni correction) only in the right caudate (t = 2.87, P = 0.01; d.f. = 16, independent samples t-test) and in the left putamen (t = 3.00, P = 0.008). The associations between the clinical variables and the averaged (left + right) FDOPA K i values of the caudate and putamen among index subjects are shown in Table 3. No marked associations ( r 0.50) were found 157 Table 1 Patient/control characteristics Controls Patients Age 44.2 ± ± 6.0 MAST 3.0 ± ± 9.6 Age of alcohol dependence onset ± 8.9 Years of heavy alcohol use ± 9.6 WAIS-R ± ± 12.0 WCST error percentage 23.0 ± ± 14.8 Figure 1 The unchanged fraction of 6-[ 18 F]-L-FDOPA in arterial plasma of controls and alcohol-dependent patients (data from eight patients). The error bars denote s.d.
3 Dopamine function in alcoholism 158 Figure 2 Integrated 6[ 18 F]-L-FDOPA PET image and a corresponding MRI image of an alcohol-dependent patient. Note the low uptake of 6-[ 18 F]-L-FDOPA in the head of left caudate (arrow). The corresponding structure is depicted with an arrow in the MRI image resliced according to the PET image. Table 2 The mean ± s.d. FDOPA K i values among alcoholic patients (n = 10) and matched healthy controls (n = 8). P-values have been obtained with independent t-test, d.f. = 16 Controls (n = 8) Patients (n = 10) t P Putamen (right) ± ± Putamen (left) ± ± Caudate (right) ± ± Caudate (left) ± ± between the clinical variables and the average striatal FDOPA uptake, except between WCST scores and striatal K i values. The correlations between the WCST performance scores and K i values among controls were small ( r 0.35). Those two patients with the lowest K i values in the left caudate had also the longest duration of dependence (30 and 29 years). MRI-scans showed moderate cortical atrophy in two patients and mild cortical atrophy in four patients. Cortical atrophy did not correlate markedly with K i values either in caudate (r = 0.25) or in putamen (r = 0.12). The average IQ of patients in WAIS-R was ± 12.0 points (range ), and ± 6.2 points among controls (difference N.S.). Discussion The FDOPA K i value is an index of presynaptic DA synthetic capacity and as such does not directly tell the intrasynaptic concentrations of dopamine. Recent 6-[ 18 F]-L-FDOPA PET studies on amphetamineinduced changes in primate striatum suggest, however, a good correspondence between directly measured DA levels and FDOPA K i values. 28 The mean FDOPA K i values in the left and the right caudate and in the left and the right putamen were higher among alcoholic patients when compared with matched healthy controls, but the differences were statistically significant only in the right caudate and the left putamen at group level. The results do not give support to the hypothesis of generally decreased striatal dopamine turnover in type 1 alcoholism, but on the contrary indicate an increased dopamine synthesis in the striatum. A markedly low striatal presynaptic dopamine activity was observed in the left caudate in two patients, which implies that type 1 alcoholism is probably a heterogeneous disorder concerning its molecular aetiology. The very low FDOPA activity observed in the left caudate of two patients is of interest as lesions of the left caudate have been observed to be associated with depressive symptoms. 29 However, our patients with low activity in this region clearly did not have more depressive symptoms than other index subjects (scores 31 and 45 points; mean ± s.d ± 7.3). The very low
4 Dopamine function in alcoholism 159 Figure 3 The scatter plots of striatal FDOPA K i values among alcoholic patients and controls. Table 3 The Spearman correlations between the clinical variables and the averaged FDOPA K i values (left + right: 2) of caudate and putamen among index subjects Variable r (Spearman) Putamen Caudate Duration of dependence Duration of abstinence SADQ MAST Zung/anxiety Zung/depression WCST/errors % 0.56 * 0.49 ** WAIS-R * P = 0.09; ** P = dopamine turnover in the left caudate of two patients may be secondary to long-lasting ethanol exposure, or it may reflect an inborn neurobiological variation which results in vulnerability to relatively severe, early-onset alcoholism. The results imply that the dopamine function is not significantly associated with striatal atrophy or with the recent ethanol intake (time of abstinence), or otherwise, the ethanol-induced effect is very long lasting and stable over time. The learning of new rules and the ability to modify one s behavior can be studied with WCST. Clinical data accumulated during the last decades imply that patients with frontal lobe lesions have poor WCST performance. Our results showed an association between the K i values in both caudate and putamen and the WCST scores, although the finding did not reach statistical significance (P-values 0.09 and 0.15) due to the relatively small number of subjects. The observed moderately high negative correlation between the performance in the WCST and the striatal FDOPA uptake among alcoholics is in line with experimental animal studies which imply that impaired dopaminergic function is associated with deficits in cognitive processing, 30 and with the fact that prefrontal cortex and basal ganglia have intense functional interactions. The results in WCST were not explained by poor overall cognitive performance, since mean Wechsler Adult Intelligence Scale Revised (WAIS-R) score of alcoholics was 111 points. The elevated FDOPA uptake (which correlated to poor WCST performance) may be a secondary mechanism to compensate for poor postsynaptic dopamine function in alcoholic subjects. If it is a trait-dependent variable, it may be associated with poor ability to modify one s behavior and with the development of addiction. There may be several different primary pathophysiological mechanisms in alcohol dependence. In vivo PET and single photon emission tomography (SPECT) receptor and transporter studies are not able to provide explicit information on the overall function of the dopaminergic transmission. The low D 2 receptor den-
5 160 Dopamine function in alcoholism sity and affinity measured with [ 11 C] raclopride binding can be explained by the decreased number of receptors per synapse or by decreased number of synapses such as in Parkinson s disease (PD) or, alternatively, by increased endogenous synaptic dopamine activity which competes in D 2 binding with the ligand. In the same way, the low DA transporter density can be explained by the decreased number of synapses as in PD or by the normal number of synapses with decreased number of transporters per synapse. One possibility is that some type 1 alcoholics have disturbed postsynaptic dopamine transmission eg at the level of D 2 receptor binding or due to dysfunction of G-protein second messenger systems. This could lead to a compensatory increase in the presynaptic dopamine synthesis and compensatory decrease in DA reuptake, which would both increase dopamine transmission, but despite this, possibly not achieving the normal level of transmission. The observed great dispersion in striatal dopamine activity in the left caudate among our patients may be associated with the vulnerability to development of addiction, which suggests that drugs stabilizing dopamine transmission such as partial dopamine agonists might be relevant novel candidates for the pharmacological treatment of type 1 alcoholism. This class of drugs such as (+) -UH might be used to dampen the rapid transients in dopamine release during acute ethanol-induced euphoria. A partial agonist would not decrease dopamine transmission in the long run, but would prevent rapid changes in dopamine release which may be associated with the reinforcement and development of addiction. Conclusions The results do not give support to the hypothesis of generally decreased striatal dopamine turnover in type 1 alcoholism but, on the contrary, indicate an increased presynaptic dopamine synthesis. This may represent a compensatory mechanism to low postsynaptic DA function. The low presynaptic DA function observed in the left caudate of two patients suggests that type 1 alcoholism may be a heterogeneous disorder. The observed high correlation between the poor performance in the WCST and the elevated striatal FDOPA uptake is in line with experimental animal studies which imply that impaired dopaminergic function is associated with learning deficits. If the increased presynaptic DA synthesis is a trait-dependent variable, it may be associated with disability to modify one s behavior and with the development of addiction. The observed great dispersion in the striatal dopamine activity in the left caudate among our patients may be associated with the vulnerability to development of addiction, which suggests that drugs stabilizing dopamine transmission such as partial dopamine agonists might be relevant novel candidates for the pharmacological treatment of type 1 alcoholism. References 1 Rossetti ZL, D Aquila PS, Hmaidan Y, Gessa GL, Serra G. Repeated treatment with imipramine potentiates cocaine-induced dopamine release and motor stimulation. Eur J Pharmacol 1991; 201: Sorensen SM, Jumphreys TM, Taylor VL, Schmidt CJ. 5-HT 2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis. J Pharm Exp Ther 1992; 260: Spanagel R, Herz A, Bals-Kubik R, Shippenberg TS. -endorphininduced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology (Berlin) 1991; 104: Yoshimoto K, McBride WJ, Lumeng L, Li T-K. Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol 1991; 9: Kaliva PW. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Revs 1993; 18: Dyr W, McBride WJ, Lumen L, Li T-K, Murphy JM. Effects of D 1 and D 2 dopamine receptor agents on ethanol consumption in the high-alcohol-drinking (HAD) line of rats. Alcohol 1993; 10: Caine SB, Koob GF. Modulation of cocaine self-administration in the rat through D 3 dopamine receptors. Science 1993; 260: Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P et al. Allelic association of human dopamine D 2 receptor gene in alcoholism. JAMA 1990; 263: Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast E et al. The dopamine D 2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 1991; 266: Smith SS, O Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D et al. Genetic vulnerability of drug abuse: the D 2 dopamine receptor TagI B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry 1992; 49: Hietala J, Pohjalainen T, Heikkilä-Kallio U, West C, Salaspuro M, Syvälahti E. Allelic association between D2 but not D1 dopamine receptor gene and alcoholism in Finland. J Psy Gen 1997; in press. 12 Gelernter J, O Malley S, Risch N, Kranzler HR, Krystal J, Merikangas K et al. No association between an allele at the D 2 dopamine receptor gene (DRD2) and alcoholism. JAMA 1991; 266: Goldman D, Dean M, Brown GL, Bolos AM, Tokola R, Virkkunen M et al. D 2 dopamine receptor genotype and cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid and 3-methoxy-4- hydroxyphenylglycol in alcoholics in Finland and the United States. Acta Psychiatr Scand 1993; 86: Goldman D, Brown GL, Albaugh B et al. D 2 dopamine receptor genotype, linkage disequilibrium and dopamine duction in Finnish, American Indian and US Caucasian alcoholics and the population association approach in psychogenetics. Alcohol Clin Exp Res 1993; 17: Cloninger CR. D 2 dopamine receptor gene is associated but not linked with alcoholism. JAMA 1991; 266: Gelernter J, Goldman D, Risch N. The A1 allele at the D 2 dopamine receptor gene and alcoholism: a reappraisal. JAMA 1993; 269: Uhl G, Blum K, Noble E, Smith S. Substance abuse vulnerability and D 2 receptor genes. Trends Neurosci 1993; 16: Noble EP, Blum K, Ritschie T, Montgomery A, Sheridan PJ. Allelic association of the D 2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991; 48: Cloninger CR. Neurogenetic adaptive mechanisms in alcoholism. Science 1987; 236: Hietala J, West C, Syvälahti E, Någren K, Lehikoinen P, Sonninen P et al. Striatal D 2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology 1994; 116: Tiihonen J, Kuikka J, Bergström K, Hakola P, Karhu J, Ryynänen O-P et al. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nature Med 1995; 1:
6 22 Cloninger CR. The psychobiological regulation of social cooperation. Nature Med 1995; 1: Volkov ND, Wang G-J, Fowler JS, Logan J, Hitzemann R, Ding Y-S et al. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 1996; 20: Bergman J, Haaparanta M, Lehikoinen P, Solin O. Electrophilic synthesis of 6-[ 18 F]-fluoro-L-dopa starting from aqueous [ 18 F]-fluoride. J Label Comp Radipharm 1994; XXXV: Hietala J, Syvälahti E, Vuorio K, Räkköläinen V, Bergman J, Haaparanta M et al. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 1995; 346: Pellizari CA, Chen GTY, Spelbring DR, Weichselbaum RR, Chen CT. Accurate three dimensional registration of CT, PET and/or MRI images of the brain. J Comp Ass Tomography 1989; 13: Dopamine function in alcoholism 27 Patlak CS, Blasberg RG, Fernstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: Melega WP, Quintana J, Raleigh MJ, Stout DB, Yu DC, Lin KP et al. 6-[ 18 F]fluoro-L-dopa PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys. Synapse 1996; 22: Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain 1987; 110: Goldman-Rakic PS. Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA 1996; 93: Carlsson A. Dopamine autoreceptor agonists in the treatment of schizophrenia. Neuropsychopharmacology 1994; 10(3S): 119S. 161
D 2 receptors binding potential is not affected by Taq1 polymorphism at the D 2 receptor gene
Molecular Psychiatry (1998) 3, 261 265 1998 Stockton Press All rights reserved 1359 4184/98 $12.00 ORIGINAL RESEARCH ARTICLE D 2 receptors binding potential is not affected by Taq1 polymorphism at the
More informationParkinsonism or Parkinson s Disease I. Symptoms: Main disorder of movement. Named after, an English physician who described the then known, in 1817.
Parkinsonism or Parkinson s Disease I. Symptoms: Main disorder of movement. Named after, an English physician who described the then known, in 1817. Four (4) hallmark clinical signs: 1) Tremor: (Note -
More informationUvA-DARE (Digital Academic Repository) SPECT imaging in young patients with schizophrenia Lavalaye, J. Link to publication
UvA-DARE (Digital Academic Repository) SPECT imaging in young patients with schizophrenia Lavalaye, J. Link to publication Citation for published version (APA): Lavalaye, J. (2001). SPECT imaging in young
More information- Neurotransmitters Of The Brain -
- Neurotransmitters Of The Brain - INTRODUCTION Synapsis: a specialized connection between two neurons that permits the transmission of signals in a one-way fashion (presynaptic postsynaptic). Types of
More informationThe Neuroscience of Addiction: A mini-review
The Neuroscience of Addiction: A mini-review Jim Morrill, MD, PhD MGH Charlestown HealthCare Center Massachusetts General Hospital Disclosures Neither I nor my spouse/partner has a relevant financial relationship
More informationUnderstanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationMOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre
1 MOLECULAR BIOLOGY OF DRUG ADDICTION Sylvane Desrivières, SGDP Centre Reward 2 Humans, as well as other organisms engage in behaviours that are rewarding The pleasurable feelings provide positive reinforcement
More informationUnderstanding L-dopa L and Metabolism in the Human Brain
Understanding L-dopa L Transport and Metabolism in the Human Brain Final Presentation for REU program August 3, 2006 Megan Mary Mekarski Advisor: Professor Linninger Dr. Libin Zhang Laboratory for Product
More informationThe Neurobiology of Mood Disorders
The Neurobiology of Mood Disorders J. John Mann, MD Professor of Psychiatry and Radiology Columbia University Chief, Department of Neuroscience, New York State Psychiatric Institute Mood Disorders are
More informationChemical Control of Behavior and Brain 1 of 9
Chemical Control of Behavior and Brain 1 of 9 I) INTRO A) Nervous system discussed so far 1) Specific 2) Fast B) Other systems extended in space and time 1) Nonspecific 2) Slow C) Three components that
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationNeurotransmitter Functioning In Major Depressive Disorder
Neurotransmitter Functioning In Major Depressive Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. 2017 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD January
More informationNeurophysiology and Neurochemistry in PsychoGeriatrics
Tel Aviv University Sackler Faculty of Medicine CME in Psychiatry Neurophysiology and Neurochemistry in PsychoGeriatrics Nicola Maggio, MD, PhD Sackler Faculty of Medicine Tel Aviv University Department
More informationAmerica is a drugged society
Overview of Drug Abuse Basic Considerations. M. Imad Damaj, Ph.D. Associate Professor Dept. of Pharmacology/Toxicology, Virginia Commonwealth University America is a drugged society 90% of all drugs manufactured
More informationThe Biological Perspective. Jørg Mørland Senior researcher, Norwegian Institute of Public Health Professor em of Medicine University of Oslo
The Biological Perspective Jørg Mørland Senior researcher, Norwegian Institute of Public Health Professor em of Medicine University of Oslo The Biological Perspective What is it? More than «the» one biological
More information한국인알코올리즘과 Catechol-O-methyltransferase COMT 유전자다형성의연합
KISEP Original Articles 생물정신의학 Vol. 8, No. 1, June 2001 한국인알코올리즘과 Catechol-O-methyltransferaseCOMT 유전자다형성의연합 김민정 1 양병환 2 이정식 3 채영규 4 박택규 5 An Association Study of COMT Gene Polymorphism with Korean Alcoholism
More informationClasses of Neurotransmitters. Neurotransmitters
1 Drugs Outline 2 Neurotransmitters Agonists and Antagonists Cocaine & other dopamine agonists Alcohol & its effects / Marijuana & its effects Synthetic & Designer Drugs: Ecstasy 1 Classes of Neurotransmitters
More informationBrain Imaging studies in substance abuse. Jody Tanabe, MD University of Colorado Denver
Brain Imaging studies in substance abuse Jody Tanabe, MD University of Colorado Denver NRSC January 28, 2010 Costs: Health, Crime, Productivity Costs in billions of dollars (2002) $400 $350 $400B legal
More informationRound table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation
Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation 1. Reflection of Mild Cognitive Impairment (MCI) and Dementias by Molecular Imaging, PET
More informationCogs 107b Systems Neuroscience lec9_ neuromodulators and drugs of abuse principle of the week: functional anatomy
Cogs 107b Systems Neuroscience www.dnitz.com lec9_02042010 neuromodulators and drugs of abuse principle of the week: functional anatomy Professor Nitz circa 1986 neurotransmitters: mediating information
More informationNEUROBIOLOGY ALCOHOLISM
NEUROBIOLOGY ALCOHOLISM THERE HAS BEEN A MAJOR THEORETICAL SHIFT IN MEDICATION DEVELOPMENT IN ALCOHOLISM Driven by animal models of intermittent ethanol administration followed by termination, then access
More informationDrugs, The Brain, and Behavior
Drugs, The Brain, and Behavior John Nyby Department of Biological Sciences Lehigh University What is a drug? Difficult to define Know it when you see it Neuroactive vs Non-Neuroactive drugs Two major types
More informationbiological psychology, p. 40 The study of the nervous system, especially the brain. neuroscience, p. 40
biological psychology, p. 40 The specialized branch of psychology that studies the relationship between behavior and bodily processes and system; also called biopsychology or psychobiology. neuroscience,
More informationDo we still believe in the dopamine hypothesis? New data bring new evidence
International Journal of Neuropsychopharmacology (24), 7 (Supplement 1), S1 S5. Copyright f 24 CINP DOI : 1.117/S146114574411 Do we still believe in the dopamine hypothesis? New data bring new evidence
More informationSchizophrenic twin. Normal twin
Brain anatomy and activity are often abnormal in schizophrenics - many studies have found the ventricles in schizophrenic patients enlarged (see below). - at the structural level, several brain areas have
More informationNeurobiology of Addiction
Neurobiology of Addiction Domenic A. Ciraulo, MD Director of Alcohol Pharmacotherapy Research Center for Addiction Medicine Department of Psychiatry Massachusetts General Hospital Disclosure Neither I
More informationTO BE MOTIVATED IS TO HAVE AN INCREASE IN DOPAMINE. The statement to be motivated is to have an increase in dopamine implies that an increase in
1 NAME COURSE TITLE 2 TO BE MOTIVATED IS TO HAVE AN INCREASE IN DOPAMINE The statement to be motivated is to have an increase in dopamine implies that an increase in dopamine neurotransmitter, up-regulation
More informationUnit 3: The Biological Bases of Behaviour
Unit 3: The Biological Bases of Behaviour Section 1: Communication in the Nervous System Section 2: Organization in the Nervous System Section 3: Researching the Brain Section 4: The Brain Section 5: Cerebral
More informationNEUROIMAGING IN PANS/PANDAS
NEUROIMAGING IN PANS/PANDAS Harry T. Chugani, M.D. Chief, Pediatric Neurology Nemours A.I. dupont Hospital for Children Wilmington, Delaware, USA Professor of Pediatrics and Neurology Thomas Jefferson
More informationPET, especially with 6-18 F-fluoro-L-dopa ( 18 F-FDOPA)
Journal of Nuclear Medicine, published on May 14, 2009 as doi:10.2967/jnumed.108.061572 Simple Ratio Analysis of F-Fluorodopa Uptake in Striatal Subregions Separates Patients with Early Parkinson Disease
More informationESSENTIAL PSYCHOPHARMACOLOGY, Neurobiology of Schizophrenia Carl Salzman MD Montreal
ESSENTIAL PSYCHOPHARMACOLOGY, 2011 Neurobiology of Schizophrenia Carl Salzman MD Montreal EVOLVING CONCEPTS OF SCHIZOPHRENIA Psychotic illness with delusions, hallucinations, thought disorder and deterioration;
More informationNEUROCOGNITIVE, OUTCOMES IN PKU: IT S TIME TO RAISE THE BAR
NEUROCOGNITIVE, OUTCOMES IN : IT S TIME TO RAISE THE BAR KEY POINTS 1. High Phenylalanine (Phe) levels harm the brain.. Traditional therapies do not completely protect individuals with. 3. New approaches
More informationC81ADD Psychology of Addiction. Alcohol. Ethyl alcohol (ethanol) School of Psychology. Tobias Bast.
C81ADD Psychology of Addiction Alcohol Ethyl alcohol (ethanol) Tobias Bast School of Psychology tobias.bast@nottingham.ac.uk 1 Selected aspects of the psychopharmacology of alcohol (ethanol) Primary neuropharmacological
More informationMaking Things Happen 2: Motor Disorders
Making Things Happen 2: Motor Disorders How Your Brain Works Prof. Jan Schnupp wschnupp@cityu.edu.hk HowYourBrainWorks.net On the Menu in This Lecture In the previous lecture we saw how motor cortex and
More informationSupplementary Online Content
Supplementary Online Content Jauhar S, Nour MM, Veronese M, et al. A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder
More informationImaging Neurotransmitter Release by Drugs of Abuse
Imaging Neurotransmitter Release by Drugs of Abuse Diana Martinez and Rajesh Narendran Contents 1 Positron Emission Tomography Radioligand Imaging................................... 220 2 Using PET to
More informationPsychotropic Drugs Critical Thinking - KEY
Open Your Class with This Tomorrow Chasing the Scream: The First and Last Days of the War on s Psychotropic s Critical Thinking - KEY Background: The blood-brain barrier is a network of tightly packed
More informationWhat are Substance Use Disorders?
What are Substance Use Disorders? Sanchit Maruti, MD Michael Goedde, MD University of Vermont Medical Center 1 Disclosures } Drs. Maruti and Goedde receive compensation as consultants to the American Academy
More informationThe Nervous System Mark Stanford, Ph.D.
The Nervous System Functional Neuroanatomy and How Neurons Communicate Mark Stanford, Ph.D. Santa Clara Valley Health & Hospital System Addiction Medicine and Therapy Services The Nervous System In response
More informationReporting a Case of Injecting Methylphenidate (Ritalin) Tablets, Intensified Symptoms of Schizoph-renia or Induce Separate Mental Disorder?
Case Report Addiction and Health Vol 1, No 2, Fall 2009 Received: 6.10.2009 Accepted:17.11.2009 Background: Case Report: Conclusion: Key words: Page count: Tables: Figures: References: Address of Correspondence:
More informationDownloaded from Interaction of neurotransmitters with alcohol in cases of depression
INTERACTION OF NEUROTRANSMITTERS WITH ALCOHOL IN CASES OF DEPRESSION Dr. Anil Batta Professor & Head, Dep t of Medical Biochemistry GGS medical college, Baba Farid Univ.of health sciences, Faridkot. ISSN
More informationThe Nervous System. Biological School. Neuroanatomy. How does a Neuron fire? Acetylcholine (ACH) TYPES OF NEUROTRANSMITTERS
Biological School The Nervous System It is all about the body!!!! It starts with an individual nerve cell called a NEURON. Synapse Neuroanatomy Neurotransmitters (chemicals held in terminal buttons that
More informationName: Period: Chapter 2 Reading Guide The Biology of Mind
Name: Period: Chapter 2 Reading Guide The Biology of Mind The Nervous System (pp. 55-58) 1. What are nerves? 2. Complete the diagram below with definitions of each part of the nervous system. Nervous System
More informationSPECT Dopamin Transporter lmaging Agent
SPECT Dopamin Transporter lmaging Agent Product Summary Product Name DATrace-123 Injection Active Ingredient Action Mechanism DATrace-123 is used as a radiopharmaceutical for the SPECT imaging of Dopamine
More informationUsefulness of a dopamine transporter PET ligand [ 18 F]β-CFT in assessing disability in Parkinson s disease
J Neurol Neurosurg Psychiatry 1999;67:737 741 737 Department of Neurology, University of Turku; Turku PET Centre, Turku, Finland J O Rinne H Ruottinen Department of Radiology, P Sonninen Radiochemistry
More informationThe Biology of Addiction
The Biology of Addiction Risk factors for addiction: Biological/Genetic Family history of addiction Being male Having mental illness Exposure to substances in utero * The genes that people are born with
More informationThe Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison
The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison Attitudes about addiction and recovery throughout history Disease?
More informationprocesses in the central nervous system (CNS), affecting many of the during the course of ethanol treatment. Ethanol stimulates the release of
INTRODUCTION INTRODUCTION Neuroscience research is essential for understanding the biological basis of ethanol-related brain alterations and for identifying the molecular targets for therapeutic compounds
More informationPain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction
PAIN Ò 153 (2012) 744 754 www.elsevier.com/locate/pain Comprehensive review Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction Johanna M. Jarcho a,b, Emeran
More informationAnalysis of [ 11 C]L-deprenyl-D2 (DEP-D) brain PET studies
Turku PET Centre Modelling report TPCMOD0033 2006-05-26 Vesa Oikonen Analysis of [ 11 C]L-deprenyl-D2 (DEP-D) brain PET studies Introduction L-deprenyl and monoamine oxidase B Monoamine oxidase B (MAO
More informationMethods of Visualizing the Living Human Brain
Methods of Visualizing the Living Human Brain! Contrast X-rays! Computerized Tomography (CT)! Magnetic Resonance Imaging (MRI)! Positron Emission Tomography (PET)! Functional MRI! Magnetoencephalography
More informationExcited Delirium and Sudden Death. William A. Cox, M.D., FCAP Forensic Pathologist/Neuropathologist. December 14, 2018
Excited Delirium and Sudden Death William A. Cox, M.D., FCAP Forensic Pathologist/Neuropathologist December 14, 2018 The entity, Excited Delirium Syndrome, has been the focus of much discussion over the
More informationThinking Outside the Box: Prescribing by Synthesis & Integration
Thinking Outside the Box: Prescribing by Synthesis & Integration Barbara J. Limandri, DNSc, APRN, BC Linfield College School of Nursing Portland DBT Program AGENDA Neuroanatomy and neurophysiology review
More informationSupplemental Data. Inclusion/exclusion criteria for major depressive disorder group and healthy control group
1 Supplemental Data Inclusion/exclusion criteria for major depressive disorder group and healthy control group Additional inclusion criteria for the major depressive disorder group were: age of onset of
More informationChapter 2: Studies of Human Learning and Memory. From Mechanisms of Memory, second edition By J. David Sweatt, Ph.D.
Chapter 2: Studies of Human Learning and Memory From Mechanisms of Memory, second edition By J. David Sweatt, Ph.D. Medium Spiny Neuron A Current Conception of the major memory systems in the brain Figure
More informationPositron Emission Tomography: Tool to Facilitate Drug Development and to Study Pharmacokinetics
Positron Emission Tomography: Tool to Facilitate Drug Development and to Study Pharmacokinetics Robert B. Innis, MD, PhD Molecular Imaging Branch National Institute Mental Health 1 Outline of Talk 1. PET
More informationCell body, axon, dendrite, synapse
SOME BASIC NEUROSCIENCE Neurons have specialised extensions 1: Label the parts of a neuron by selecting the correct term from the box below. Cell body, axon, dendrite, synapse 1 dendrite synapse cell body
More informationFacility IBA 18/9 Cyclotron Accelerates p and d. Facility GMP Grade Clean Room Automated Dispenser Synthera Rig FDG 07/11/2014
Dr Chris Marshall Director Introduction to PET Positron Emission Tomography Positron is anti matter equivalent of the electron Isotopes that are proton rich can decay by emission of a positron Positron
More informationNeurotransmitter Systems Studied with Positron Emission Tomography. By Lauri Tuominen
Neurotransmitter Systems Studied with Positron Emission Tomography By Lauri Tuominen Outline of talk 1. Neurotransmission what is it? 2. Basic principles 3. Examples of study designs Why PET? PET imaging
More informationFatigue in patients with Parkinson s disease
103 Fatigue in patients with Parkinson s disease Kazuo Abe, Mayako Takanashi and Takehiko Yanagihara Department of Neurology, Osaka University Graduate School of Medicine, Japan Purpose: Fatigue is a complaint
More informationThe Neurobiology of Drug Addiction
The Neurobiology of Drug Addiction Glen R. Hanson, Ph.D., D.D.S. Director, Utah Addiction Center Professor of Pharmacology and Toxicology, U of U Senior Advisor, NIDA Drug Abuse and Addiction are Among
More informationAt a Glance. Background Information. Lesson 3 Drugs Change the Way Neurons Communicate
Lesson 3 Drugs Change the Way Neurons Communicate Overview Students build upon their understanding of neurotransmission by learning how different drugs of abuse disrupt communication between neurons. Students
More informationShort communication. dwk&:key words: Parkinson s disease Single-photon emission tomography Dopamine transporter imaging Aging. Materials and methods
Short communication [ 123 I]β-CIT single-photon emission tomography in Parkinson s disease reveals a smaller decline in dopamine transporters with age than in controls G. Tissingh 1, P. Bergmans 1, J.
More informationBody control systems. Let s start at the top: the human brain. The Cerebrum. The human brain. What parts of your brain are you using right now?
What parts of your brain are you using right now? Body control systems Quick Sends message directly to target organ Endocrine system Frontal lobe Parietal lobe Movement and conscious thought; Frontal speech
More informationThe Nervous System. Chapter 4. Neuron 3/9/ Components of the Nervous System
Chapter 4 The Nervous System 1. Components of the Nervous System a. Nerve cells (neurons) Analyze and transmit information Over 100 billion neurons in system Four defined regions Cell body Dendrites Axon
More informationReinforcement learning and the brain: the problems we face all day. Reinforcement Learning in the brain
Reinforcement learning and the brain: the problems we face all day Reinforcement Learning in the brain Reading: Y Niv, Reinforcement learning in the brain, 2009. Decision making at all levels Reinforcement
More informationBasal ganglia Sujata Sofat, class of 2009
Basal ganglia Sujata Sofat, class of 2009 Basal ganglia Objectives Describe the function of the Basal Ganglia in movement Define the BG components and their locations Describe the motor loop of the BG
More informationCourse Calendar - Neuroscience
2006-2007 Course Calendar - Neuroscience Meeting Hours for entire semester: Monday - Friday 1:00-2:20 p.m. Room 1200, COM August 28 August 29 August 30 August 31 September 1 Course introduction, Neurocytology:
More informationExam 2 PSYC Fall (2 points) Match a brain structure that is located closest to the following portions of the ventricular system
Exam 2 PSYC 2022 Fall 1998 (2 points) What 2 nuclei are collectively called the striatum? (2 points) Match a brain structure that is located closest to the following portions of the ventricular system
More informationPSYCH 260 Exam 2. March 2, Answer the questions using the Scantron form. Name:
PSYCH 260 Exam 2 March 2, 2017 Answer the questions using the Scantron form. Name: 1 1 Main Please put in their proper order the steps that lead to synaptic communication between neurons. Begin with the
More informationPositron Emission Tomography: Tool to Facilitate Drug Development and to Study Pharmacokinetics
Positron Emission Tomography: Tool to Facilitate Drug Development and to Study Pharmacokinetics Robert B. Innis, MD, PhD Molecular Imaging Branch National Institute Mental Health 1 Outline of Talk 1. PET
More informationOrganization of the nervous system. [See Fig. 48.1]
Nervous System [Note: This is the text version of this lecture file. To make the lecture notes downloadable over a slow connection (e.g. modem) the figures have been replaced with figure numbers as found
More informationThe Nobel Prize in Physiology or Medicine 2000
The Nobel Prize in Physiology or Medicine 2000 Press Release NOBELFÖRSAMLINGEN KAROLINSKA INSTITUTET THE NOBEL ASSEMBLY AT THE KAROLINSKA INSTITUTE 9 October 2000 The Nobel Assembly at Karolinska Institutet
More informationThe Cerebral Cortex and Higher Intellectual Functions
The Cerebral Cortex and Higher Intellectual Functions The Cerebral cortex consists of 2 cerebral hemisphere and each hemisphere consists of 5 lobes (frontal, parietal,temporal,occipital,insular lobe which
More informationTeach-SHEET Basal Ganglia
Teach-SHEET Basal Ganglia Purves D, et al. Neuroscience, 5 th Ed., Sinauer Associates, 2012 Common organizational principles Basic Circuits or Loops: Motor loop concerned with learned movements (scaling
More informationCurricular Requirement 3: Biological Bases of Behavior
Curricular Requirement 3: Biological Bases of Behavior Name: Period: Due Key Terms for CR 3: Biological Bases of Behavior Key Term Definition Application Acetylcholine (Ach) Action potential Adrenal glands
More informationThe Cerebral Cortex and Higher Intellectual Functions
The Cerebral Cortex and Higher Intellectual Functions Lobes in a lateral view of left hemisphere Atlas Fig.2-11 The Insula The Hidden Lobe Atlas Fig. 2-11 Atlas Fig. 2-39 Lobes in a lateral view of left
More informationWhat Have We Learned from Molecular Imaging Studies of Dopamine Neurotransmission in Schizophrenia and in Mediating Reward Behaviors
What Have We Learned from Molecular Imaging Studies of Dopamine Neurotransmission in Schizophrenia and in Mediating Reward Behaviors Robert M Kessler, MD Professor of Radiology University of Alabama at
More informationThe study of drugs. Pharmacology
The study of drugs Pharmacology Psychopharmacology The study of psychoactive drugs Psychoactive drugs Drugs that influence psychological processes mood emotion perception cognition behavior Psychoactive
More informationAP Psychology Chapter 3 Test
AP Psychology Chapter 3 Test Please make all marks on the Scan-Tron provided. Multiple Choice 1. In the opening vignette, what did the 5 million people who had fallen ill at the beginning of the 20 th
More informationDOES THE D 3 DOPAMINE RECEPTOR (D 3 r)play A ROLE IN ADDICTION? Isabelle Boileau, PhD
DOES THE D 3 DOPAMINE RECEPTOR (D 3 r)play A ROLE IN ADDICTION? Isabelle Boileau, PhD Acknowledgments Human Neurochemical Pathology Lab Stephen J. Kish, PhD Jun Chao Tong, PhD Centre for Movement Disorders
More informationAbstracts and affiliations
Dopamine Discovery Day August 30, 2012 Rikshospitalet Store auditorium, Oslo, Norway Organized by Linda H. Bergersen & Vidar Gundersen Institute of Basic Medical Sciences & Centre for Molecular Biology
More informationBody control systems. Nervous system. Organization of Nervous Systems. The Nervous System. Two types of cells. Organization of Nervous System
Body control systems Nervous system Nervous system Quick Sends message directly to target organ Endocrine system Sends a hormone as a messenger to the target organ Slower acting Longer lasting response
More informationEffects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director
Effects of Marijuana On Brain, Body & Behavior Nora D. Volkow, MD Director Marijuana is the Most Commonly Used Illicit Drug In the U.S. Over 111 million Americans have tried it at least once An estimated
More informationPSYC& 100: Biological Psychology (Lilienfeld Chap 3) 1
PSYC& 100: Biological Psychology (Lilienfeld Chap 3) 1 1 What is a neuron? 2 Name and describe the functions of the three main parts of the neuron. 3 What do glial cells do? 4 Describe the three basic
More informationThe Role of NEUROIMAGING In Diagnostic and Clinical Practice
The Role of NEUROIMAGING In Diagnostic and Clinical Practice ADHD Schizophrenia Autism Addiction Altzheimer s Disease Nora D. Volkow, M.D. Director National Institute on Drug Abuse National Institutes
More informationTo understand AD, it is important to
To understand AD, it is important to know a bit about the brain. This part of Unraveling the Mystery gives an inside view of the normal brain, how it works, and what happens during aging. The brain is
More informationCourse Calendar
Clinical Neuroscience BMS 6706C Charles, Ph.D., Course Director charles.ouimet@med.fsu.edu (850) 644-2271 2004 2005 Course Calendar Click here to return to the syllabus Meeting Hours for entire semester:
More informationStudy Guide Unit 3 Psych 2022, Fall 2003
Psychological Disorders: General Study Guide Unit 3 Psych 2022, Fall 2003 1. What are psychological disorders? 2. What was the main treatment for some psychological disorders prior to the 1950 s? 3. What
More informationFDOPA, C11Choline, C11 Methionine. Dr K.G.Kallur
FDOPA, C11Choline, C11 Methionine Dr K.G.Kallur Why? 11C Methionine scan Had undergone resection Earlier. Post op recurrent hypercalcemia C11 Methionine Unable to see in Sestamibi scan Brain Tumor After
More informationAcetylcholine (ACh) Action potential. Agonists. Drugs that enhance the actions of neurotransmitters.
Acetylcholine (ACh) The neurotransmitter responsible for motor control at the junction between nerves and muscles; also involved in mental processes such as learning, memory, sleeping, and dreaming. (See
More informationChapter 17. Nervous System Nervous systems receive sensory input, interpret it, and send out appropriate commands. !
Chapter 17 Sensory receptor Sensory input Integration Nervous System Motor output Brain and spinal cord Effector cells Peripheral nervous system (PNS) Central nervous system (CNS) 28.1 Nervous systems
More informationPSY 302 Lecture 6: The Neurotransmitters (continued) September 12, 2017 Notes by: Desiree Acetylcholine (ACh) CoA + Acetate Acetyl-CoA (mitochondria) (food, vinegar) + Choline ChAT CoA + ACh (lipids, foods)
More informationPHARMACOLOGY Vol. I - Neuropsychopharmacology - Mirjam A.F.M. Gerrits and Jan M. van Ree
NEUROPSYCHOPHARMACOLOGY Mirjam A.F.M. Gerrits and Jan M. van Ree Rudolf Magnus Institute of Neuroscience, Department of Neuroscience and Pharmacology, Universiteitsweg 100, 3584 CG Utrecht, The Netherlands
More informationSchizophrenia: Biology and Etiology. Schizophrenia: The basics. What is schizophrenia? Good Question!!
Schizophrenia: Biology and Etiology Carlsson and Lindqvist 1963 Daniel R. Weinberger, M.D. Genes, Cognition and Psychosis Program National Institute of Mental Health, NIH Bethesda, Maryland 20892 USA weinberd@mail.nih.gov
More informationORIGINAL CONTRIBUTION. Cognitive Impairment and the Brain Dopaminergic System in Parkinson Disease
ORIGINAL CONTRIBUTION Cognitive Impairment and the Brain Dopaminergic System in Parkinson Disease [ 18 F]Fluorodopa Positron Emission Tomographic Study Juha O. Rinne, MD, PhD; Raija Portin, PsychLic; Hanna
More informationThe Neurobiology of Addiction
The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly
More informationRecent Findings on Dopamine in the Pathophysiology of Schizophrenia. Cristy A. Ku Whittier College
40 Recent Findings on Dopamine in the Pathophysiology of Schizophrenia Cristy A. Ku Whittier College The original dopamine hypothesis (Carlsson & Lindqvist, 1963 as cited in Laruelle, Abi-Dargham, Gil,
More informationOutline. Biological Psychology: Research Methods. Dr. Katherine Mickley Steinmetz
Biological Psychology: Research Methods Dr. Katherine Mickley Steinmetz Outline Neuroscience Methods Histology Electrophysiological Recordings Lesion Neuroimaging Neuroanatomy Histology: Brain structure
More informationMethamphetamine Increases, and HIV Decreases, Brain Volumes
NIDA - Publications - NIDA Notes - Vol. 20, No. 6 - Research Findings of 4 http://archives.drugabuse.gov/nida_notes/nnvol20n6/increases.html NIDA Home > Publications > NIDA Notes > Vol. 20, No. 6 > Research
More information